We are live on ! Find out more
GGS

Galvin Gaustad & Stein Portfolio holdings

AUM $1.36B
1-Year Est. Return 18.83%
This Fund
S&P 500
This Quarter Est. Return
+9.79%
1 Year Est. Return
+18.83%
3 Year Est. Return
+53.69%
5 Year Est. Return
+52.9%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$82.3M
Cap. Flow
-$11.5M
Cap. Flow %
-1.07%
Top 10 Hldgs %
27.45%
Holding
187
New
19
Increased
56
Reduced
92
Closed
4

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.78M
2
BF.B icon
Brown-Forman Class B
BF.B
+$6.92M
3
CSCO icon
Cisco
CSCO
+$6.23M
4
PG icon
Procter & Gamble
PG
+$5.66M
5
ZM icon
Zoom
ZM
+$4.39M

Top Sells

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$18.5M
2
DIS icon
Walt Disney
DIS
+$16.3M
3
TFC icon
Truist Financial
TFC
+$12M
4
HON icon
Honeywell
HON
+$3.12M
5
UPS icon
United Parcel Service
UPS
+$3.11M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 10.11%
2 Technology 9.28%
3 Healthcare 8.8%
4 Financials 8.57%
5 Consumer Staples 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHF icon
176
Schwab International Equity ETF
SCHF
$67B
$213K 0.02%
+11,550
New +$200K
VBK icon
177
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
$209K 0.02%
+864
New +$188K
INTU icon
178
Intuit
INTU
$86.3B
$207K 0.02%
+332
New +$183K
BA icon
179
Boeing
BA
$175B
$207K 0.02%
+794
New +$170K
IYJ icon
180
iShares US Industrials ETF
IYJ
$1.97B
$206K 0.02%
+1,800
New +$188K
DFAC icon
181
Dimensional US Core Equity 2 ETF
DFAC
$47.7B
$205K 0.02%
+7,025
New +$190K
IWB icon
182
iShares Russell 1000 ETF
IWB
$47.9B
$204K 0.02%
+777
New +$190K
XLV icon
183
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$200K 0.02%
+1,469
New +$191K
BTI icon
184
British American Tobacco
BTI
$133B
-17,636
Closed -$554K
DVN icon
185
Devon Energy
DVN
$50.9B
-6,414
Closed -$306K
MO icon
186
Altria Group
MO
$113B
-5,083
Closed -$214K
XLC icon
187
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
-3,060
Closed -$201K

Similar funds

Galvin Gaustad & Stein's Q4 2023 Portfolio in Review

As of Q4 2023, Galvin Gaustad & Stein held 187 positions worth $1.07B, up 8.3% from $987M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Galvin Gaustad & Stein's Q4 2023 filing shows 19 new, 56 increased, 92 reduced and 4 closed positions. Its largest new stake was Vertex Pharmaceuticals: 21,047 shares worth $8.56M. The largest sale was Cognizant, an estimated $18.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 10% of assets, up from 9.8% a quarter earlier, followed by Technology and Healthcare.

  • Galvin Gaustad & Stein's largest Q4 2023 buy was Vertex Pharmaceuticals: 21,047 shares worth $8.56M.
  • Galvin Gaustad & Stein added most to Brown-Forman Class B in Q4 2023, an estimated $6.92M increase.
  • Galvin Gaustad & Stein's biggest Q4 2023 reduction was Cognizant, cutting an estimated $18.5M.
  • Galvin Gaustad & Stein fully exited British American Tobacco in Q4 2023, selling an estimated $554K.
  • Galvin Gaustad & Stein's ten largest holdings make up 27% of its $1.07B portfolio in Q4 2023.
  • Galvin Gaustad & Stein opened 19 new positions and closed 4 in Q4 2023.
  • Galvin Gaustad & Stein's portfolio value rose 8.3% quarter-over-quarter to $1.07B.

Based on Galvin Gaustad & Stein's 13F filing for Q4 2023, filed 11 Jan 2024.